Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers-In Vitro Studies.

Gurbi B, Brauswetter D, Varga A, Gyulavári P, Pénzes K, Murányi J, Zámbó V, Birtalan E, Krenács T, Becker DL, Csala M, Vályi-Nagy I, Peták I, Dános K.

Cancers (Basel). 2019 Nov 22;11(12). pii: E1848. doi: 10.3390/cancers11121848.

2.

Novel Crizotinib-GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems.

Murányi J, Varga A, Gyulavári P, Pénzes K, Németh CE, Csala M, Pethő L, Csámpai A, Halmos G, Peták I, Vályi-Nagy I.

Int J Mol Sci. 2019 Nov 8;20(22). pii: E5590. doi: 10.3390/ijms20225590.

3.

Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers.

Pethő L, Murányi J, Pénzes K, Gurbi B, Brauswetter D, Halmos G, Csík G, Mező G.

Int J Mol Sci. 2019 Oct 11;20(20). pii: E5027. doi: 10.3390/ijms20205027.

4.

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues.

Murányi J, Varga A, Gurbi B, Gyulavári P, Mező G, Vántus T.

J Vis Exp. 2017 Mar 21;(121). doi: 10.3791/55529.

5.

Synthesis, characterization and systematic comparison of FITC-labelled GnRH-I, -II and -III analogues on various tumour cells.

Murányi J, Gyulavári P, Varga A, Bökönyi G, Tanai H, Vántus T, Pap D, Ludányi K, Mező G, Kéri G.

J Pept Sci. 2016 Aug;22(8):552-60. doi: 10.1002/psc.2904.

PMID:
27443981

Supplemental Content

Loading ...
Support Center